Skip navi

About Us

KOLON Pharma is committed to
improve the health of mankind and quality of life.

History

2000년~Present
2018
Authorized the international standard of ISO 37001 - Anti-bribery management systems.
2017
Launched Invossa-K for Korean market
Received grade A in the evaluation of Fair Trade Compliance Program,
organized by Korea Fair Trade Commission
2016
Signed the MoU with Woonginliliette
Launched Apniben Q Sol. for Korean market
(First Diclofenac mouthwash in Korea for oral inflammation)
2015
Launched Levoplus Tab. 750mg for Korean market
(First Levofloxacin 750mg in Korea)
2014
Signed the license agreement for AB-Dentalac and I3.1 with AB-Biotics
Passed the due diligence by Japan PMDA
(Pharmaceuticals and Medical Devices Agency)
and received the permit to export the finished drugs to Japan
2013
Certified of overseas manufacturing site in Japan
2012
Signed the license agreement for Diclofenac Spray with Farmaka
Developed MES / LMS /QMS system in all processes
2011
Signed the license agreement for Diclofenac Mouthwash with Farmaka
Received the Sharing Practice Merit (Ministry of Health and Welfare)
2009
Launched Foster for Korean market (composite inhaled asthma treatment drug)
2008
Signed the license agreement for Vismed with Trb
Signed the license agreement for Clipper and 4 other products with Chiesi
Selected as an outstanding labor relationship award
(Ministry of Employment and Labor)
Appointed Woo-seok Lee as CEO
Launched Topisol for Korean market (Korea's first lotion type MPA)
2007
Signed the license agreement for Toraymyxin with Toray
Signed the license agreement for Inhaler and 4 other products with Chiesi
Signed the license agreement for Carnaculin with Sanwa
2003
Bicogreen, received the First Brand Award (The Korea Economic Daily)
"Launched Curosurf for Korean market
(infantile respiratory distress syndrome treatment)
2002
Designated as BGMP company (Ministry of Food and Drug Safety No. 49)
1990~1999
1999
Launched Comy Syrup for Korean market (sinus cold treatment)
1998
Designated as KGSP company (Ministry of Health and Welfare No. 116)
1997
Signed the technology alliance with SS
1994
Launched Bicogreen tablet for Korean market (constipation treatment)
1992
Designated as KGMP company (Ministry of Health and Welfare No. 105)
Moved and expanded the KGMP factory (Daejun)
Constructed Daejun Factory
1990
Changed the name to KOLON Pharma
Signed the technology alliance with Chiesi
1958~1989
1989
Signed the technology alliance with Nippon Organon
1983
Acquired by KOLON Group as to be an affiliate
1958
established “Samyeong Chemical”
top